Pharmafile Logo
Pharmafocus logo
Advanced Search

Dermatology

Showing 15 posts of 25 posts found.

Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness

October 3, 2025
Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

UCB announces first-in-patient trial success for galvokimig in atopic dermatitis

September 18, 2025
Medical Communications, Research and Development Dermatology, UCB, atopic dermatitis, clinical trial

UCB has reported positive early clinical trial results for galvokimig, an investigational therapy for adults with moderate-to-severe atopic dermatitis (AD). …

News

Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis

July 21, 2025
Medical Communications, Mergers and Acquisitions, Research and Development Boehringer Ingelheim, Dermatology, LEO Pharma, Spevigo, generalised pustular psoriasis, partnership, skin disease

Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a treatment for generalised pustular psoriasis …

News
Toast Burning

Five facts about UV exposure and sun safety

July 7, 2025
Medical Communications Dermatology, Five Facts, Oncology, Skin, melanoma, skincare

1We can acclimatise to UV exposure. For example, we’re more likely to burn if there’s a sunny spell earlier in …

Feature

LEO Pharma appoints Helle Hedegaard Juhl as EVP of global people & corporate affairs

July 7, 2025
Manufacturing and Production Dermatology, Helle Hedegaard Juhl, LEO Pharma, Skin, dermatology

Danish dermatology company, LEO Pharma, announced the appointment of new executive vice president (EVP) of global people and corporate affairs, …

Appointment
Jens Holstein, Alexandra Ogilvie and Ulrich Dauer

Mallia strengthens its advisory board as it accelerates hair loss treatment

July 7, 2025
Manufacturing and Production Dermatology, Skin, biopharma, dermatology, hair loss, mallia

German dermatology company, Mallia Innovations, has appointed Jens Holstein, Alexandra Ogilvie and Ulrich Dauer to its advisory board, strengthening its …

Appointment

Galderma launches clinical trials for nemolizumab in systemic sclerosis and chronic pruritus of unknown origin

June 27, 2025
Research and Development Dermatology, Galderma, chronic pruritus of unknown origin, clinical trials, dermatological conditions, dermatology, nemolizumab, systemic sclerosis

Galderma has announced the launch of two phase 2 clinical trials evaluating its monoclonal antibody, nemolizumab, in two conditions: systemic …

News

NICE recommends spevigo for rare and severe psoriasis flares

June 20, 2025
Medical Communications, Research and Development Dermatology, NHS, National Institute for Health and Care Excellence, generalised pustular psoriasis

The National Institute for Health and Care Excellence (NICE) has recommended Spevigo (spesolimab) for the treatment of generalised pustular psoriasis …

News
clinical_trials

Dupixent improves symptoms in patients with skin of colour, study shows

June 11, 2025
Advocacy Development, Medical Education, Research and Development Dermatology, Dupixent, Regeneron, Sanofi, atopic dermatitis, dermatology, underserved populations

Sanofi and Regeneron have announced results from the collaborative phase 4 DISCOVER study, presented at the Revolutionizing Atopic Dermatitis Conference, …

News
cream-4713579_1920

LEO Pharma initiates phase 2a trial of delgocitinib cream for rare skin condition

June 3, 2025
Research and Development Dermatology, LEO Pharma, Skin, clinical trial, delgocitinib cream, rare skin condition

LEO Pharma has initiated a phase 2a trial investigating delgocitinib cream in adults with mild-to-severe palmoplantar pustulosis (PPP). The DELTA …

News

DEBRA Research and Dermaliq Therapeutics collaborate to advance treatment for rare skin disorder

May 29, 2025
Research and Development DEBRA Research, Dermaliq Therapeutics, Dermatology, epidermolysis bullosa, non-profit organisation, skin disorders

Global non-profit organisation, DEBRA Research, and clinical dermatology company, Dermaliq Therapeutics, have announced a collaboration to advance drug development for …

News

UK Researcher Wins Prestigious IBSA Foundation Fellowship for Pioneering Dermatology Study

May 28, 2025
Medical Communications, Research and Development Dermatology, IBSA Foundation Fellowship, Institut Biochimique SA (IBSA), Masami Ando Kuri, Milan Italy, Wellcome Sanger Institute, dermatology

Masami Ando Kuri from the Wellcome Sanger Institute named one of six global winners of the 2024 IBSA Foundation Fellowships. …

News
Press release

Boehringer Ingelheim’s Spevigo gains additional approvals in US and China

March 20, 2024
Medical Communications Boehringer Ingelheim, Dermatology, FDA, Spevigo, psoriasis

Boehringer Ingelheim has announced that Spevigo (spesolimab-sbzo) has been approved by the US Food and Drug Administration (FDA) for the …

News

Sanofi shares phase 2b results for dermatitis treatment

March 12, 2024
Research and Development Dermatology, Sanofi, amlitelimab, atopic dermatitis, clinical trial, dermatitis

Sanofi has shared positive results from part 2 of the investigational phase 2b STREAM-AD study of amlitelimab for adult patients …

News

Almirall licenses Novo Nordisk’s anti-IL-21 monoclonal antibody for dermatology treatment

February 23, 2024
Research and Development Almirall, Dermatology, Novo Nordisk, dermatology, monoclonal antibody

Almirall has announced that it has entered into an exclusive license agreement with Novo Nordisk for the rights to its …

News
The Gateway to Local Adoption Series

Latest content

Evotec and Bayer announce new kidney disease study

December 11, 2025

Actithera appoints Darshan Dalal as Chief Medical Officer

December 11, 2025

Pace appoints Ken Beyer as CEO

December 10, 2025

EpilepsyGTx raises $33m for focal refractory epilepsy gene therapy

December 10, 2025

Breast Cancer Now study to explore personalised drug doses

December 9, 2025